Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
HIV entry as antiviral strategy — Myriam Witvrouw (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
HIV entry as antiviral strategy
Shared by
De Clercq Erik
KU Leuven
HIV entry as antiviral strategy
Article
2002
en
Related publications
Article
2001
CXCR4 antagonists as HIV entry inhibitors
Katrien Princen
,
Sigrid Hatse
,
Kurt Vermeire
,
Gary Bridger
,
Renato T. Skerlj
,
De Clercq Erik
,
Dominique Schols
Article
2020
Imposed mutational meltdown as an antiviral strategy
Jeffrey D. Jensen
,
Ryan A. Stikeleather
,
Timothy F. Kowalik
,
Authors
MW
Myriam Witvrouw
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Michael E Lynch
Article
2012
Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors
Wenwen Chen
,
Peng Zhan
,
De Clercq Erik
,
Xinyong Liu
Article
2005
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
Sigrid Hatse
,
Katrien Princen
,
De Clercq Erik
,
Mette M. Rosenkilde
,
Thue W. Schwartz
,
Pedro E. Hernandez-Abad
,
Renato T. Skerlj
,
Gary Bridger
,
Dominique Schols
Article
2000
Viral Entry as the Primary Target for the Anti-HIV Activity of Chicoric Acid and Its Tetra-Acetyl Esters
Wim Pluymers
,
Nouri Neamati
,
Christophe Pannecouque
,
Valery Fikkert
,
Christophe Marchand
,
Terrence R. Burke
,
Yves Pommier
,
Dominique Schols
,
De Clercq Erik
,
Zeger Debyser
,
Myriam Witvrouw
Discussion(0)
No comments yet. Be the first to comment.